The Impact of New Options for DAA-Experienced Patients With HCV
Current Management of NASH
NASH: State of the Science, Epidemiology, Pathophysiology, and Natural History
Emerging Directions in the Management of NASH
Expert Answers to Frequently Asked Questions Regarding HCV Elimination in Key Patient Populations
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
Clinical Care Options, LLC. All Rights Reserved.